Seymour, J. F., Marcus, R., Davies, A., Gallop-Evans, E., Grigg, A., Haynes, A., Herold, M., Illmer, T., Nilsson-Ehle, H., Sökler, M., Dünzinger, U., Nielsen, T., Launonen, A. and Hiddemann, W. (2019) “Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression”, Haematologica. Pavia, Italy, 104(6), pp. 1202-1208. doi: 10.3324/haematol.2018.209015.